Healthcare commercialization outfit PDI buys RedPath Integrated Pathology just days after rejecting a tentative buyout offer from Digirad.
PDI has bought RedPath Integrated Pathology just days after rejecting a tentative buyout offer from Digirad Corp. (NSDQ:DRAD).
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DUhgrG
Cap comentari:
Publica un comentari a l'entrada